Galderma Acquires ZO Skin Health from Blackstone for $1.5 Billion

Key Facts

Galderma has agreed to acquire ZO Skin Health from Blackstone in a deal valued at approximately $1.5 billion. Investing.com reported that the acquisition allows Galderma to expand its premium skincare portfolio while providing an exit for Blackstone from its investment in the brand.

Blackstone Inc. (BX) shares closed at $114.78 on October 12, 2026, with the stock reaching a day high of $114.85 and a low of $113.47 during that session. The transaction aligns with Galderma's strategy to strengthen its position in the professional skincare market by integrating ZO Skin Health's assets.